Point72 Hong Kong’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,699
Closed -$61K 1218
2022
Q3
$61K Buy
18,699
+12,684
+211% +$57.3K ﹤0.01% 1372
2022
Q2
$29K Buy
6,015
+4,275
+246% +$26.3K ﹤0.01% 1478
2022
Q1
$13K Sell
1,740
-1,601
-48% -$12.4K ﹤0.01% 1575
2021
Q4
$31K Buy
+3,341
New +$35.5K ﹤0.01% 1466
2021
Q2
Sell
-2,866
Closed -$52K 2241
2021
Q1
$52K Buy
+2,866
New +$38.8K ﹤0.01% 1278

Other funds holding ORGO

Point72 Hong Kong's ORGO Position: Q4 2022 in Review

Point72 Hong Kong sold out of Organogenesis Holdings (ORGO) in Q4 2022, closing a stake of 18,699 shares — an estimated $61K sold.

Point72 Hong Kong first reported a position in ORGO in Q1 2021 and held it in 5 quarters. The position peaked at $61K in Q3 2022. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Point72 Hong Kong reported no remaining Organogenesis Holdings position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 18,699 Organogenesis Holdings shares in Q4 2022, an estimated $61K.
  • Point72 Hong Kong first reported a position in Organogenesis Holdings in Q1 2021 and held it in 5 quarters.
  • Point72 Hong Kong's Organogenesis Holdings position peaked at $61K in Q3 2022.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.